Earth Science Tech Inc. (OTC: ETST) reported fiscal year 2026 results for the year ended March 31, 2026, highlighting growth across key financial metrics as it continues to operate its diversified holdings model spanning healthcare, pharmaceuticals, telemedicine, real estate and consumer businesses. Revenue increased 8% to $35.7 million, gross profit rose 5% to $25.5 million, net income grew 11% to $3.6 million, and total assets increased 27% to $9 million.
CEO Giorgio R. Saumat attributed the results to ETST's efforts to fully integrate the patient experience across telemedicine to pharmacy to fulfillment. The company's core value proposition lies in the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries.
The fiscal 2026 performance underscores the potential of ETST's vertically integrated healthcare platform, which combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. Healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business.
As a diversified holding company focused on health and wellness, Earth Science Tech operates with the principal strategy of building a connected ecosystem that streamlines patient access to treatments. The company's subsidiaries work in concert to reduce friction in the healthcare delivery chain, potentially improving outcomes and patient satisfaction.
Investors can find the latest news and updates relating to ETST in the company's newsroom at https://nnw.fm/ETST. For more information about Earth Science Tech, visit www.EarthScienceTech.com.
The full article detailing these results is available at https://nnw.fm/u6mhk.
